Yeo KK - Search Results

1

A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.

Lim-Fat MJ, Cotter JA, Touat M, Vogelzang J, Sousa C, Pisano W, Geduldig J, Bhave V, Driver J, Kao PC, McGovern A, Ma C, Margol AS, Cole K, Smith A, Goldman S, Kaneva K, Truong AL, Nazemi KJ, Wood MD, Wright KD, London WB, Warren KE, Wen PY, Bi WL, Alexandrescu S, Reardon DA, Ligon KL, Yeo KK. Lim-Fat MJ, et al. Among authors: yeo kk. Neuro Oncol. 2024 Jul 31:noae142. doi: 10.1093/neuonc/noae142. Online ahead of print. Neuro Oncol. 2024. PMID: 39082676

2

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G. Robison NJ, et al. Among authors: yeo kk. J Neurooncol. 2018 May;138(1):199-207. doi: 10.1007/s11060-018-2791-y. Epub 2018 Feb 9. J Neurooncol. 2018. PMID: 29427149 Free PMC article. Clinical Trial.

3

A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.

Margol AS, Yeo KK, Xia C, Onar A, Robison NJ, Freyer DR, Dhall G. Margol AS, et al. Among authors: yeo kk. J Neurooncol. 2018 Dec;140(3):575-582. doi: 10.1007/s11060-018-2983-5. Epub 2018 Sep 1. J Neurooncol. 2018. PMID: 30173409 Free PMC article.

4

Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution.

Kaneva K, Yeo KK, Hawes D, Ji J, Biegel JA, Nelson MD, Bluml S, Krieger MD, Erdreich-Epstein A. Kaneva K, et al. Among authors: yeo kk. JCO Precis Oncol. 2019;3:PO.18.00138. doi: 10.1200/PO.18.00138. Epub 2019 Mar 27. JCO Precis Oncol. 2019. PMID: 31179415 Free PMC article. No abstract available.

5

Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.

Yeo KK, Kayser K, Margol AS, Wong KK, Robison N, Finlay J, Dhall G. Yeo KK, et al. Pediatr Blood Cancer. 2019 Dec;66(12):e27983. doi: 10.1002/pbc.27983. Epub 2019 Sep 10. Pediatr Blood Cancer. 2019. PMID: 31502379

6

Increasing value of autopsies in patients with brain tumors in the molecular era.

Ahrendsen JT, Filbin MG, Chi SN, Manley PE, Wright KD, Bandopadhayay P, Clymer JR, Yeo KK, Kieran MW, Jones R, Lidov HG, Ligon KL, Alexandrescu S. Ahrendsen JT, et al. Among authors: yeo kk. J Neurooncol. 2019 Nov;145(2):349-355. doi: 10.1007/s11060-019-03302-z. Epub 2019 Sep 30. J Neurooncol. 2019. PMID: 31571114

7

Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.

Yeo KK, Margol AS, Kennedy RJ, Hung L, Robison NJ, Dhall G, Asgharzadeh S. Yeo KK, et al. J Neurooncol. 2019 Nov;145(2):375-383. doi: 10.1007/s11060-019-03307-8. Epub 2019 Oct 16. J Neurooncol. 2019. PMID: 31621042 Free PMC article.

8

Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.

Cooney T, Yeo KK, Kline C, Prados M, Haas-Kogan D, Chi S, Mueller S. Cooney T, et al. Among authors: yeo kk. Neurooncol Pract. 2020 Jan;7(1):4-10. doi: 10.1093/nop/npz033. Epub 2019 Aug 13. Neurooncol Pract. 2020. PMID: 32257279 Free PMC article. Review.

9

Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature.

Michaiel G, Strother D, Gottardo N, Bartels U, Coltin H, Hukin J, Wilson B, Zelcer S, Hansford JR, Hassall T, AbdelBaki MS, Cole KA, Hoffman L, Smiley NP, Smith A, Vinitsky A, Vitanza NA, Wright A, Yeo KK, Chow LML, Vanan MI, Dhall G, Bouffet E, Lafay-Cousin L. Michaiel G, et al. Among authors: yeo kk. J Neurooncol. 2020 May;147(3):721-730. doi: 10.1007/s11060-020-03486-9. Epub 2020 Apr 15. J Neurooncol. 2020. PMID: 32297094 Review.

10

Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.

Cacciotti C, Choi J, Alexandrescu S, Zimmerman MA, Cooney TM, Chordas C, Clymer J, Chi S, Yeo KK. Cacciotti C, et al. Among authors: yeo kk. J Neurooncol. 2020 Aug;149(1):113-122. doi: 10.1007/s11060-020-03578-6. Epub 2020 Jul 5. J Neurooncol. 2020. PMID: 32627129 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters